Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma (Q33385558)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma |
scientific article |
Statements
1 reference
Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma (English)
1 reference
Ranjana Advani
1 reference
Andres Forero-Torres
1 reference
Richard R Furman
1 reference
Joseph D Rosenblatt
1 reference
Anas Younes
1 reference
Hong Ren
1 reference
Kate Harrop
1 reference
Nancy Whiting
1 reference
Jonathan G Drachman
1 reference
1 reference
Identifiers
1 reference